Left Ventricular Thrombus Following Acute Myocardial Infarction: JACC State-of-the-Art Review

A Camaj, V Fuster, G Giustino, SW Bienstock… - Journal of the American …, 2022 - jacc.org
The incidence of left ventricular (LV) thrombus following acute myocardial infarction has
markedly declined in recent decades caused by advancements in reperfusion and …

Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines

W Ageno, AS Gallus, A Wittkowsky, M Crowther… - Chest, 2012 - Elsevier
Background The objective of this article is to summarize the published literature concerning
the pharmacokinetics and pharmacodynamics of oral anticoagulant drugs that are currently …

Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association

JF Meschia, C Bushnell, B Boden-Albala, LT Braun… - Stroke, 2014 - Am Heart Assoc
The aim of this updated statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of stroke among individuals who have not previously …

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart …

PT O'Gara, FG Kushner, DD Ascheim, DE Casey… - Journal of the American …, 2013 - jacc.org
1.1. Methodology and Evidence Review The recommendations listed in this document are,
whenever possible, evidence based. The current document constitutes a full revision and …

Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial

PJ Devereaux, E Duceppe, G Guyatt, V Tandon… - The Lancet, 2018 - thelancet.com
Background Myocardial injury after non-cardiac surgery (MINS) increases the risk of
cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran …

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation …

PT O'gara, FG Kushner, DD Ascheim, DE Casey Jr… - Circulation, 2013 - Am Heart Assoc
The recommendations listed in this document are, whenever possible, evidence based. The
current document constitutes a full revision and includes an extensive evidence review …

Apixaban with antiplatelet therapy after acute coronary syndrome

JH Alexander, RD Lopes, S James… - … England Journal of …, 2011 - Mass Medical Soc
Background Apixaban, an oral, direct factor Xa inhibitor, may reduce the risk of recurrent
ischemic events when added to antiplatelet therapy after an acute coronary syndrome …

Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial

AL Dans, SJ Connolly, L Wallentin, S Yang… - Circulation, 2013 - Am Heart Assoc
Background—The Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY)
trial showed that dabigatran etexilate 150 mg BID was superior and dabigatran etexilate 110 …

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines

J Ansell, J Hirsh, E Hylek, A Jacobson, M Crowther… - Chest, 2008 - Elsevier
This article concerning the pharmacokinetics and pharmacodynamics of vitamin K
antagonists (VKAs) is part of the American College of Chest Physicians Evidence-Based …

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation …

Authors/Task Force Members… - European heart …, 2008 - academic.oup.com
Document Reviewers: Sigmund Silber (CPG Review Coordinator)(Germany), Frank V.
Aguirre (USA), Nawwar Al-Attar (France), Eduardo Alegria (Spain), Felicita Andreotti (Italy) …